Literature DB >> 27252509

HOXA-activated early T-cell progenitor acute lymphoblastic leukemia: predictor of poor outcome?

Jules Pp Meijerink1, Kirsten Canté-Barrett2, Eric Vroegindeweij2, Rob Pieters3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27252509      PMCID： PMC5013942          DOI： 10.3324/haematol.2016.145391

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  21 in total

1.  HOXA cluster deregulation in T-ALL associated with both a TCRD-HOXA and a CALM-AF10 chromosomal translocation.

Authors:  J Bergeron; E Clappier; B Cauwelier; N Dastugue; C Millien; E Delabesse; K Beldjord; F Speleman; J Soulier; E Macintyre; V Asnafi
Journal:  Leukemia       Date:  2006-06       Impact factor: 11.528

2.  t(10;11)(p13-14;q14-21): a new recurrent translocation in T-cell acute lymphoblastic leukemias. Groupe Français de Cytogénétique Hématologique (GFCH).

Authors: 
Journal:  Genes Chromosomes Cancer       Date:  1991-11       Impact factor: 5.006

3.  Cryptic XPO1-MLLT10 translocation is associated with HOXA locus deregulation in T-ALL.

Authors:  Jonathan Bond; Aurélie Bergon; Amandine Durand; Isabelle Tigaud; Xavier Thomas; Vahid Asnafi; Salvatore Spicuglia; Elizabeth Macintyre
Journal:  Blood       Date:  2014-11-06       Impact factor: 22.113

4.  Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia.

Authors:  L Lo Nigro; E Mirabile; M Tumino; C Caserta; G Cazzaniga; C Rizzari; D Silvestri; B Buldini; E Barisone; F Casale; M Luciani; F Locatelli; C Messina; C Micalizzi; A Pession; R Parasole; N Santoro; G Masera; G Basso; M Aricò; M Valsecchi; A Biondi; V Conter
Journal:  Leukemia       Date:  2013-05-14       Impact factor: 11.528

Review 5.  Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond.

Authors:  Chun-Wei Chen; Scott A Armstrong
Journal:  Exp Hematol       Date:  2015-06-25       Impact factor: 3.084

6.  Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.

Authors:  Elaine Coustan-Smith; Charles G Mullighan; Mihaela Onciu; Frederick G Behm; Susana C Raimondi; Deqing Pei; Cheng Cheng; Xiaoping Su; Jeffrey E Rubnitz; Giuseppe Basso; Andrea Biondi; Ching-Hon Pui; James R Downing; Dario Campana
Journal:  Lancet Oncol       Date:  2009-01-13       Impact factor: 41.316

7.  The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia.

Authors:  Pieter Van Vlierberghe; Martine van Grotel; Joëlle Tchinda; Charles Lee; H Berna Beverloo; Peter J van der Spek; Andrew Stubbs; Jan Cools; Kyosuke Nagata; Maarten Fornerod; Jessica Buijs-Gladdines; Martin Horstmann; Elisabeth R van Wering; Jean Soulier; Rob Pieters; Jules P P Meijerink
Journal:  Blood       Date:  2008-02-25       Impact factor: 22.113

8.  Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment.

Authors:  Vahid Asnafi; Kheira Beldjord; Emmanuelle Boulanger; Béatrice Comba; Patricia Le Tutour; Marie-Hélène Estienne; Frédéric Davi; Judith Landman-Parker; Pierre Quartier; Agnès Buzyn; Eric Delabesse; Françoise Valensi; Elizabeth Macintyre
Journal:  Blood       Date:  2002-11-21       Impact factor: 22.113

9.  An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.

Authors:  Jonathan Bond; Tony Marchand; Aurore Touzart; Agata Cieslak; Amélie Trinquand; Laurent Sutton; Isabelle Radford-Weiss; Ludovic Lhermitte; Salvatore Spicuglia; Hervé Dombret; Elizabeth Macintyre; Norbert Ifrah; Jean-François Hamel; Vahid Asnafi
Journal:  Haematologica       Date:  2016-03-04       Impact factor: 9.941

10.  Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation.

Authors:  Adolfo A Ferrando; Scott A Armstrong; Donna S Neuberg; Stephen E Sallan; Lewis B Silverman; Stanley J Korsmeyer; A Thomas Look
Journal:  Blood       Date:  2003-03-13       Impact factor: 22.113
View more
  3 in total

1.  RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD.

Authors:  Ali Sakhdari; Beenu Thakral; Sanam Loghavi; Rashmi Kanagal-Shamanna; C Cameron Yin; Zhuang Zuo; Mark J Routbort; Rajyalakshmi Luthra; L Jeffrey Medeiros; Sa A Wang; Keyur P Patel; Chi Young Ok
Journal:  Cancer Med       Date:  2019-12-05       Impact factor: 4.452

Review 2.  Early precursor T-cell acute lymphoblastic leukemia: current paradigms and evolving concepts.

Authors:  Omar Castaneda Puglianini; Nikolaos Papadantonakis
Journal:  Ther Adv Hematol       Date:  2020-07-16

3.  HOXD13 promotes the malignant progression of colon cancer by upregulating PTPRN2.

Authors:  Jiangyan Yin; Yi Guo
Journal:  Cancer Med       Date:  2021-07-17       Impact factor: 4.452
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.